Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma × Protons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Meningioma 2 HER2-positive Breast Cancer 2 Glioma 2 Glioblastoma 2 Chordoma 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sarcoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Radiation Injuries 1 Pituitary Neoplasms 1 Oligodendroglioma 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lung Neoplasms 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1

Interventions

Doxorubicin 119 Ifosfamide 70 Radiotherapy 64 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Docetaxel 34 pazopanib 33 Etoposide 33 pembrolizumab 32 Trabectedin 31 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Temozolomide 17 Radiation 16 Mesna 16 Melphalan 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Dactinomycin 15 Biopsy 15 Topotecan 14 Surgical Procedures, Operative 14 Sorafenib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04946357 2026-03-10

EXTREM ION

University Hospital Heidelberg

Phase NA Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡